Continuous dopamine-receptor stimulation in advanced Parkinson's disease

被引:134
|
作者
Nutt, JG [1 ]
Obeso, JA
Stocchi, F
机构
[1] Oregon Hlth Sci Univ, Dept Neurol, Portland, OR 97201 USA
[2] Univ Navarra, Dept Neurol, E-31080 Pamplona, Spain
[3] Univ La Sapienza, Prima Clin Neurol, I-00185 Rome, Italy
关键词
D O I
10.1016/S1471-1931(00)00029-X
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Intermittent or pulsatile dopamine-receptor stimulation is postulated to induce plastic changes in motor systems that are responsible for the development of the motor fluctuations and dyskinesia that complicate long-term L-dopa therapy of Parkinson's disease. As a corollary to this hypothesis, continuous dopamine-receptor stimulation can avoid or reverse these complications. Such continuous stimulation is unlikely to mimic completely the normal function of the dopaminergic system, but should avoid the supra-physiological swings in extracellular dopamine that accompany intermittent L-dopa dosing. The concern is that this continuous stimulation might induce tolerance rather than sensitization to some effects of L-dopa. Open clinical trials support the value of continuous dopaminergic stimulation in Parkinson's disease with established motor complications, but rigorous studies, although experimentally difficult, are needed.
引用
收藏
页码:S109 / S115
页数:7
相关论文
共 50 条
  • [1] Continuous dopamine-receptor stimulation in early Parkinson's disease
    Olanow, CW
    Schapira, AHV
    Rascol, O
    TRENDS IN NEUROSCIENCES, 2000, 23 (10) : S117 - S126
  • [2] Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications
    Olanow, C. Warren
    Obeso, Jose A.
    Stocchi, Fabrizio
    LANCET NEUROLOGY, 2006, 5 (08): : 677 - 687
  • [3] BROMOCRIPTINE AND DOPAMINE-RECEPTOR STIMULATION
    DRAY, A
    OAKLEY, NR
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (07) : 586 - 588
  • [4] THE ROLE OF PULSATILE VERSUS CONTINUOUS DOPAMINE-RECEPTOR STIMULATION FOR FUNCTIONAL RECOVERY IN PARKINSONS-DISEASE
    OBESO, JA
    GRANDAS, F
    HERRERO, MT
    HOROWSKI, R
    EUROPEAN JOURNAL OF NEUROSCIENCE, 1994, 6 (06) : 889 - 897
  • [5] Transdermal Rotigotine: A Clinically Innovative Dopamine-Receptor Agonist for the Management of Parkinson's Disease
    Chen, Jack J.
    Swope, David M.
    Dashtipour, Khashayar
    Lyons, Kelly E.
    PHARMACOTHERAPY, 2009, 29 (12): : 1452 - 1467
  • [6] Dopamine receptor agonists in the treatment of advanced Parkinson's disease
    Stocchi, Fabrizio
    PARKINSONISM & RELATED DISORDERS, 2009, 15 : S54 - S57
  • [7] Continuous transdermal dopaminergic stimulation in advanced Parkinson's disease
    Metman, LV
    Gillespie, M
    Farmer, C
    Bibbiani, F
    Konitsiotis, S
    Morris, M
    Shill, H
    Bara-Jimenez, W
    Mouradian, MM
    Chase, TN
    CLINICAL NEUROPHARMACOLOGY, 2001, 24 (03) : 163 - 169
  • [8] Continuous dopaminergic stimulation in early and advanced Parkinson's disease
    Stocchi, F
    Olanow, CW
    NEUROLOGY, 2004, 62 (01) : S56 - S63
  • [9] The rationale for continuous dopaminergic stimulation in advanced Parkinson's disease
    Nyholm, Dag
    PARKINSONISM & RELATED DISORDERS, 2007, 13 : S13 - S17
  • [10] Nonergot dopamine-receptor agonists for treating Parkinson's disease - a network meta-analysis
    Thorlund, Kristian
    Wu, Ping
    Druyts, Eric
    Eapen, Shawn
    Mills, Edward J.
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2014, 10 : 767 - 776